Abstract: . . .  repeated when restenosis occurs. References 1. Hypertension prevalence and the status of awareness, treatment and control in the Unit- ed States. Hypertension 1985; 7:457. 2. Simon N. et al. Clinical characteristics of reno- vascular hypertension . JAMA 1972; 220:1209. 3. Marks LS, Maxwell MN. Renal vein renin: value and limitations in the prediction of oper- ative results. Urol Clin North Amer 1975;2:311. 4. 1995 update of the working group ret on chronic renal failure . . .
. . .  Percutaneous transluminal angioplasty (PTA) Although cure of hypertension in patients with atherosclerotic renal disease is relatively uncommon ( = 25 percent), improvement in control has been reported in 34 percent to 90 percent of patients treated with PTA. Results with PTA are signifi- cantly better in the treatment of patients with fibro- muscular disease, with published studies reporting cure or improvement in hypertension in 76 percent to 100 percent of patients. In patients with renal . . .
. . .  PTA and stenting. An accurate comparison between PTA and stents cannot be made, however, because most patients undergoing stent placement under- went unsuccessful PTA and were at higher risk for restenosis. 5 Patients can be followed with noninva- sive studies, and revascularization can be repeated when restenosis occurs. References 1. Hypertension prevalence and the status of awareness, treatment and control in the Unit- ed States. Hypertension 1985; 7:457. 2. Simon . . .
. . .  1975;2:311. 4. 1995 update of the working group ret on chronic renal failure and renovascular hyper- tension. Arch Intern Med 1996; 156:1937- 1938. 5. Rees C. Renovascular interventions. JVIR 1996(suppl);7(1):311-314. Copyright 2004 the Society of Interventional Radiology, www.SIRweb.org  . . .
--2200,4,275,2271,10998